The global market for gastric cancer is projected to have a considerable CAGR of around 6.8% during the forecast period. Gastric cancer is one of the most common forms of cancer across the globe. In gastric cancer, the malignant cells form in the lining of the stomach and develop slowly over many years. Bacterium Helicobacter pylori is a stomach infection that is one of the primary factors for the occurrence of gastric cancer. The high prevalence of gastrointestinal stromal tumours, carcinoid tumors, and lymphoma is one of the major factors for augmenting the treatment market of gastric cancer. An increase in the number of cancer treatment facilities across the globe is another major factor for the growth of the market. According to the American Cancer Society’s estimates for stomach cancer (also known as gastric cancer) in the US for 2021, there are about 26,560 new cases of stomach cancer (16,160 in men and 10,400 in women) are diagnosed, and about 11,180 people are died due to this type of cancer (6,740 men and 4,440 women) are registered. The growing elderly population, technological advancement and rising incidence and prevalence rate of gastric cancer are boosting the stomach cancer market across the globe.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/gastric-cancer-market

The global gastric cancer market is segmented based on testing type, treatment type and end-users. Based on testing type, the market further segmented into chest x-ray, computed tomography (CT or CAT) scan, laparoscopy, magnetic resonance imaging (MRI) scan, positron emission tomography (PET) scan and Others. Similarly, on the basis of treatment type, the market is classified into chemotherapy, radiation therapy, surgery, targeted therapy, and immunotherapy. Among these, the targeted therapy segment is expected to show a significant growth rate during the forecast period. Delivery of advanced techniques including enzyme therapy and stem cell therapy is the primary factor for growth in the targeted therapy market. Targeted therapy tends to work in some cases where standard chemotherapy does not work. In such cases, trastuzumab, a targeted therapy drug, is given with chemotherapy. Based on end-user, the market is classified into hospitals & clinics, specialized cancer treatment centers and others.

A Full Report of Global Gastric Cancer Market is Available at: https://www.omrglobal.com/industry-reports/gastric-cancer-market

Geographically, the global Gastric Cancer market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, the Asia-Pacific region is expected to grow at a considerable CAGR during the forecast period. Growing disposable income, awareness and healthcare spending are the major factor driving the growth of the gastric cancer market in the region. The rising prevalence of gastric cancer in various countries such as China, Japan, South Korea will create significant market growth for gastric cancer in the region.

Global Gastric Cancer Market– Segmentation
By Testing Type
Chest X-Ray
Computed Tomography (CT OR CAT) Scan
Laparoscopy
Magnetic Resonance Imaging (MRI) Scan
Positron Emission Tomography (PET) Scan
Others (Upper Gastrointestinal (GI) Series)
By Treatment Type
Chemotherapy
Radiation Therapy
Surgery
Targeted Therapy
Immunotherapy
By End-Users
Hospitals & Clinics
Specialized Cancer Treatment Centers
Others (Ambulatory Surgical Centers)

Global Gastric Cancer Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories
ASLAN Pharmaceuticals Pte Ltd.
AstraZeneca PLC
Athenex, Inc.
Bayer AG
Biogen Inc.
Bristol Myers Squibb Co.
Celltrion, Inc.
Danaher Corp.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
ImmunoGen, Inc.
Ipsen Pharma
Merck & Co., Inc.
Novartis International AG
Otsuka Holdings Co. Ltd.
Oncolytics Biotech, Inc.
Pacific Edge Ltd.
Pfizer Inc.
Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/gastric-cancer-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404